Biogen To Acquire Nightstar Therapeutics In $800M Cash Deal.

Reuters (3/4) reports Biogen announced Monday “it will buy Nightstar Therapeutics Plc for about $800 million in cash as the company looks to tap into a potentially lucrative gene therapy market.” The Wall Street Journal (3/4, Roland, Subscription Publicat...